Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration - PubMed (original) (raw)
Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration
Robert E Drolet et al. Neurotoxicology. 2004 Sep.
Abstract
The functional role of alpha-synuclein in the pathogenesis of Parkinson's disease (PD) is not fully understood. Systemic exposure of alpha-synuclein-deficient mice to neurotoxins provides a direct approach to evaluate how alpha-synuclein may mediate cell death in a common murine model of PD. To this end, wild-type and homozygous alpha-synuclein knock-out mice were treated with sub-chronic and prolonged, chronic exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). In the sub-chronic model, wild-type and alpha-synuclein knock-out mice were treated for five consecutive days with MPTP (1-25 mg/kg, s.c.) or vehicle, and sacrificed 3 days following the last injection. The prolonged, chronic model consisted of two injections of MPTP (1-20 mg/kg, s.c.) per week for 5 weeks, with co-administration of probenecid (250 mg/kg, i.p.), and animals were sacrificed 3 weeks following the last injection. Sub-chronic administration of MPTP caused a dramatic, dose-dependent decrease in striatal dopamine (DA) concentrations, while an attenuated response was observed in alpha-synuclein knock-out mice. Similarly, prolonged, chronic administration of MPTP produced a dose-dependent decrease in striatal DA concentrations, and a corresponding loss of striatal vesicular monoamine transporter (VMAT-2) protein in wild-type mice. However, mice lacking alpha-synuclein had an attenuated loss of striatal DA concentrations, while no loss of striatal VMAT-2 protein was observed. Both sub-chronic and prolonged, chronic administration of MPTP caused an increase in the 3,4-dihydroxyphenylacetic acid (DOPAC) to DA ratio in wild-type mice, but not in mice lacking alpha-synuclein. Despite attenuated toxicity, elevated lactate concentrations were observed in alpha-synuclein knock-out mice following prolonged, chronic MPTP administration. The results of this study provide evidence that alpha-synuclein null mice have an attenuated response to the toxic effects of MPTP exposure, even over prolonged periods of time and that the biochemical sequela of a protracted insult to nigrostriatal DA neurons are distinct between mice with and without alpha-synuclein expression.
Similar articles
- Selective alterations of gene expression in mice induced by MPTP.
Xu Z, Cawthon D, McCastlain KA, Slikker W Jr, Ali SF. Xu Z, et al. Synapse. 2005 Jan;55(1):45-51. doi: 10.1002/syn.20089. Synapse. 2005. PMID: 15499605 - Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
D'Astous M, Morissette M, Tanguay B, Callier S, Di Paolo T. D'Astous M, et al. Synapse. 2003 Jan;47(1):10-4. doi: 10.1002/syn.10145. Synapse. 2003. PMID: 12422368 - [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
Nishi K, Kondo T, Narabayashi H. Nishi K, et al. No To Shinkei. 1987 Jul;39(7):663-72. No To Shinkei. 1987. PMID: 3314916 Review. Japanese. - alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.
Sidhu A, Wersinger C, Vernier P. Sidhu A, et al. FEBS Lett. 2004 May 7;565(1-3):1-5. doi: 10.1016/j.febslet.2004.03.063. FEBS Lett. 2004. PMID: 15135042 Review.
Cited by
- Model fusion, the next phase in developing animal models for Parkinson's disease.
Manning-Bog AB, Langston JW. Manning-Bog AB, et al. Neurotox Res. 2007 Apr;11(3-4):219-40. doi: 10.1007/BF03033569. Neurotox Res. 2007. PMID: 17449461 Review. - Treating Parkinson's Disease via Activation of BDNF/TrkB Signaling Pathways and Inhibition of Delta-Secretase.
Kang SS, Wu Z, Liu X, Edgington-Mitchell L, Ye K. Kang SS, et al. Neurotherapeutics. 2022 Jul;19(4):1283-1297. doi: 10.1007/s13311-022-01248-1. Epub 2022 May 20. Neurotherapeutics. 2022. PMID: 35595958 Free PMC article. - Comparison of the D2 receptor regulation and neurotoxicant susceptibility of nigrostriatal dopamine neurons in wild-type and CB1/CB2 receptor knockout mice.
Simkins TJ, Janis KL, McClure AK, Behrouz B, Pappas SS, Lehner A, Kaminski NE, Goudreau JL, Lookingland KJ, Kaplan BL. Simkins TJ, et al. J Neuroimmune Pharmacol. 2012 Sep;7(3):533-8. doi: 10.1007/s11481-012-9375-y. Epub 2012 May 27. J Neuroimmune Pharmacol. 2012. PMID: 22639229 Free PMC article. - The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease.
Benskey MJ, Perez RG, Manfredsson FP. Benskey MJ, et al. J Neurochem. 2016 May;137(3):331-59. doi: 10.1111/jnc.13570. Epub 2016 Mar 23. J Neurochem. 2016. PMID: 26852372 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources